Companion Diagnostics Market is Worth US$ 7 Billion By 2024

New York, August 11, 2018: Market Research Engine has published a new report titled as “Companion Diagnostics Market By Indication (Gastric Cancer, Lung Cancer, Colorectal Cancer, Breast Cancer, Urology, Melanoma); By Technology (Molecular Diagnostics, CISH, Immunohistochemistry, Real Time PCR, In-situ Hybridization, FISH, Gene Sequencing) and by Regional Analysis - Global Forecast by 2017 - 2024”.

The Companion Diagnostics Market is expected to exceed more than US$ 7 Billion by 2024 at a CAGR of 20% in the given forecast period.

The Companion Diagnostics Market is segmented on the lines of its Indication, Technology and regional. Basis of Indication is segmented into Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, Urology and Gastric Cancer. Based on technology it covers Immunohistochemistry, Molecular Diagnostics, In-situ Hybridization, FISH, CISH, Real Time PCR and Gene Sequencing. The Companion Diagnostics Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

Companion nosology is employed to establish who would have the benefit of treatment and it comes in handy to identify if somebody cannot be cured, however additionally conversely is injured by the employment of a selected drug used for his or her ill. Technological advancements have brought a lot of changes within the technique of illness treatment. Companion nosology is characterised by growing demand for increased personal patient treatment that provides aid suppliers and their patients an assurance concerning the treatment lead to a positive method, contrary to ancient treatment procedure. Major impact of companion diagnostic is on medical specialty medical care space.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbott Laboratories, Dako (Agilent Technologies), Roche Holdings, Qiagen NV, Seimens Helthineers, Takeda Pharmaceuticals, Myriad Genetics, Thermo Fisher Scientific, Tacogen, and Illumina Inc., among others. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

Browse Report From Here: https://www.marketresearchengine.com/companion-diagnostics-market

The Companion Diagnostics Market has been segmented as below:

The Companion Diagnostics Market is Segmented on the lines of Indication, Technology and Regional Analysis. By Indication this market is segmented on the basis of Gastric Cancer, Lung Cancer, Colorectal Cancer, Breast Cancer, Urology and Melanoma.

By Technology this market is segmented on the basis of Molecular Diagnostics its covers CISH, Immunohistochemistry its covers Real Time PCR, In-situ Hybridization its covers FISH & Gene Sequencing. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

The major driving factors of Companion Diagnostics Market are as follows:

• Companies Promoting customized medication and Targeted medical care as a new Treatment choice
• Increasing Cases of Adverse Drug Reactions
• Co-Development of Drug and Diagnostic Technology

The major restraining factors of Companion Diagnostics Market are as follows:

• High price of Drug Development and Associated Clinical Trials
• Reimbursement problems among several Countries

This report provides:

1) An overview of the global market for Companion Diagnostics Marketand related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Companion Diagnostics Market.

4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry. 

Request sample Report from here: https://www.marketresearchengine.com/companion-diagnostics-market

The scope of the report includes a detailed study of Companion Diagnostics Marketwith the reasons given for variations in the growth of the industry in certain regions.

Table of Contents:

1.    Introduction 

2.    Research Methodology

3.    Report Summary

4.    Market Overview

5.    Companion Diagnostics Market Analysis, By Indication

6.    Companion Diagnostics Market Analysis, By Technology
7.    Companion Diagnostics Market Analysis, By Region

8.    Competitive Overview
9.    Company Profiles
    9.1    Seimens Healthineers
    9.2    Roche Holdings
    9.3    Abbott Laboratories
    9.4    Dako (Agilent Technologies)
    9.5    Qiagen NV
    9.6    Illumina Inc.
    9.7    Takeda Pharmaceuticals
    9.8    Thermo Fisher Scientific
    9.9    Tacogen
    9.10    Myriad Genetics
    9.11    Others

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/